Using tramadol to measure CYP2D6 metabolism in critically ill adults

被引：0
|
作者：
Katie Lane
John J. Dixon
Denise McKeown
Atholl Johnston
Ron H. N. van Schaik
Marianne van Fessem
Iain A. M. MacPhee
Barbara J. Philips
机构：
[1] St George’s,Division of Clinical Sciences: Intensive Care
[2] University of London,General Intensive Care Unit
[3] St George’s,Analytical Services International Ltd
[4] University of London,Department of Clinical Chemistry
[5] St George’s,Division of Clinical Sciences: Renal Medicine
[6] University of London,undefined
[7] Erasmus University Medical Centre,undefined
[8] St George’s,undefined
[9] University of London,undefined
来源：
Intensive Care Medicine | 2014年 / 40卷
关键词：
Tramadol; Acute Kidney Injury; Kidney Disease Improve Global Outcome; Hepatic Drug Metabolism; CYP2D6 Metabolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1177 / 1178
页数：1
相关论文
共 50 条
  • [1] Using tramadol to measure CYP2D6 metabolism in critically ill adults
    Lane, Katie
    Dixon, John J.
    McKeown, Denise
    Johnston, Atholl
    van Schaik, Ron H. N.
    van Fessem, Marianne
    MacPhee, Iain A. M.
    Philips, Barbara J.
    INTENSIVE CARE MEDICINE, 2014, 40 (08) : 1177 - 1178
  • [2] Hepatic drug metabolism by CYP2D6 in critically ill adults with AKI: effect of phenotype and AKI severity
    K Lane
    JJ Dixon
    T Lee
    A Johnston
    R van Schaik
    M van Fessem
    IAM MacPhee
    BJ Philips
    Intensive Care Medicine Experimental, 3 (Suppl 1)
  • [3] IN VITRO COMPARATIVE INHIBITORY PROFILES OF SEVERAL CYP2D6 INHIBITORS AND METABOLIC CAPABILITIES OF CYP2D6*1, CYP2D6*2, CYP2D6*10, AND CYP2D6*17 ON TRAMADOL METABOLISM
    Nahid, N.
    Kanumuri, S.
    Sharma, A.
    Wang, D.
    Johnson, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S74 - S75
  • [4] Postmenstrual Age and CYP2D6 Polymorphisms Determine Tramadol O-demethylation in Critically Ill Neonates and Infants
    Karel Allegaert
    Ron H N van Schaik
    Steve Vermeersch
    Rene Verbesselt
    Veerle Cossey
    Christine Vanhole
    Marianne van Fessem
    Jan de Hoon
    John N van den Anker
    Pediatric Research, 2008, 63 : 674 - 679
  • [5] CYP2D6 polymorphism in relation to tramadol metabolism: A study of Faroese patients
    Halling, Jonrit
    Weihe, Pal
    Brosen, Kim
    THERAPEUTIC DRUG MONITORING, 2008, 30 (03) : 271 - 275
  • [6] Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokinetics
    Saiz-Rodriguez, Miriam
    Ochoa, Dolores
    Roman, Manuel
    Zubiaur, Pablo
    Koller, Dora
    Mejia, Gina
    Abad-Santos, Francisco
    PHARMACOGENOMICS, 2020, 21 (10) : 663 - 675
  • [7] The hypoalgesic effect of tramadol in relation to CYP2D6
    Poulsen, L
    ArendtNielsen, L
    Brosen, K
    Sindrup, SH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (06) : 636 - 644
  • [8] A Case of Respiratory Depression in a Child With Ultrarapid CYP2D6 Metabolism After Tramadol
    Orliaguet, Gilles
    Hamza, Jamil
    Couloigner, Vincent
    Denoyelle, Francoise
    Loriot, Marie-Anne
    Broly, Franck
    Garabedian, Erea Noel
    PEDIATRICS, 2015, 135 (03) : E753 - E755
  • [9] Postmenstrual age and CYP2D6 polymorphisms determine urinary tramadol O-demethylation excretion in critically ill neonates and infants
    K Allegaert
    R Verbesselt
    R Van Schaik
    J Van den Anker
    C Vanhole
    A Debeer
    J De Hoon
    Critical Care, 12 (Suppl 2):
  • [10] CYP2D6 metabolizer status and postoperative analgesia with tramadol
    Wilder-Smith, CH
    Wilkins, J
    ANESTHESIOLOGY, 1999, 91 (3A) : U416 - U416
12345